Integrating clinical and genomic features to predict response to neoadjuvant therapy in microsatellite-stable rectal cancer

Lijie Zhang, Jingwen Wang, Juefeng Wan, Yan Wang, Hui Zhang, Yaqi Wang, Fan Xia, Lijun Shen, Zhen Zhang · 2026

Read Integrating clinical and genomic features to predict response to neoadjuvant therapy in microsatellite-stable rectal cancer by Lijie Zhang, Jingwen Wang, Juefeng Wan, Yan Wang, Hui Zhang, Yaqi Wang, Fan Xia, Lijun Shen, Zhen Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13530517.txt.

Description

Lijie Zhang and co-authors look for signs that predict how rectal cancer will respond to treatment given before surgery. Their 2026 study drew on 437 patients treated at a cancer center in Shanghai between 2019 and 2023. Most tumors were of the microsatellite-stable type, the group named in the title. Gene tests on tumor and normal samples used a panel of 887 genes.

In the main group, about one third of patients had a complete response. A treatment plan that paired standard care with immunotherapy raised the odds of that result, as did a mutation in the SYNE1 gene. A mutation in KRAS pointed the other way for long term health, with one subtype linked to spread to the lungs. The team built a chart that joins clinic and gene data.

Catalog record

CREATORLijie Zhang, Jingwen Wang, Juefeng Wan, Yan Wang, Hui Zhang, Yaqi Wang, Fan Xia, Lijun Shen, Zhen Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13530517

Browse the full library · About the Tower of Babel